Clinical Study
-
Spine
Spine BioPharma Announces First Patient Treated in U.S. Phase 3 Clinical Study
SB-01 For Injection Offers New Potential Treatment for Patients Sufferingfrom Chronic Low Back Pain NEW YORK, September 7, 2022 – OrthoSpineNews…
Read More » -
Biologics
BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
— First Site Will Enroll First Patient in the Clinical Study– MELVILLE, NY., June 13, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies,…
Read More » -
Biologics
Lipogems® Receives IDE Approval From The U.S. FDA To Begin A Pivotal Clinical Study On The Safety And Effectiveness Of The Lipogems System For The Treatment of Knee Osteoarthritis
ATLANTA , June 10, 2022 /PRNewswire/ — Lipogems is pleased to announce the unconditional approval by the U.S. Food and Drug Administration (FDA) to…
Read More » -
Spine
Centinel Spine Clinical Study for Total Disc Replacement for 2-Level Symptomatic Cervical Disc Disease
SAN ANTONIO, May 24, 2022 /PRNewswire/ — Texas Spine Care Center announced today their 10th patient enrolled in the Centinel Spine, LLC, Multicenter,…
Read More » -
Spine
Spine BioPharma Initiating U.S. Phase 3 Clinical Study
SB-01 For Injection Offers New Potential Treatment for Patients Sufferingfrom Chronic Low Back Pain. New York, NY., May 11, 2022…
Read More » -
Extremities
Stryker’s InSpace subacromial balloon spacer two-year, Level 1 randomized controlled clinical study published in the Journal of Bone and Joint Surgery
InSpace implant demonstrated to be a viable option for patients with massive irreparable rotator cuff tears.* KALAMAZOO, Mich., May 3, 2022 /PRNewswire/…
Read More » -
Recon
New Study Shows No Revisions and a Low Complication Rate for Exactech’s Vantage® Total Ankle Fixed Bearing System
April 14, 2022 GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement…
Read More » -
Recon
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
Study included only patients with a fully personalized Conformis implant in one knee after previously receiving a competitive off-the-shelf implant in…
Read More » -
Biologics
aap launches world’s first human clinical study for antibacterial silver coating technology on anatomical plates and screws for fracture treatment
Press Release dated December 10, 2021 aap Implantate AG (“aap” or the “Company”) announces that the human clinical study for its…
Read More » -
Spine
Premia Spine’s TOPS™ Spinal Arthroplasty System Yields Positive Patient Outcomes at 6 Weeks Through 12 Months
Intermediate clinical study results presented at SMISS 2021 November 4, 2021 NORWALK, Conn.–(BUSINESS WIRE)–Premia Spine, a medical technology company aiming…
Read More » -
Spine
New Publication Supports Clinical Effectiveness of Centinel Spine’s STALIF® Integrated Interbody™ System
WEST CHESTER, Pa., Oct. 26, 2021 /PRNewswire/ — Centinel Spine®, LLC, a leading global medical device company addressing cervical and lumbar spinal…
Read More » -
Recon
Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants
A retrospective review of 540 procedures performed demonstrated 98.5% Implant Survivorship and 89.0% Patient Satisfaction for the Conformis patient-specific iTotal®…
Read More » -
Biologics
Prosidyan® FIBERGRAFT® Achieves High Fusion Rate in Multi-Center Clinical Study Presented at Top Neurosurgery Conference
FIBERGRAFT® BG Matrix Achieved 96.3% Fusion Rate in Posterolateral Spine Fusion Clinical Study NEW PROVIDENCE, N.J. (PRWEB) AUGUST 26, 2021 Prosidyan,…
Read More » -
Extremities
CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects
According to a Two-Year Randomized and Controlled Multinational IDE Study KFAR SABA, Israel, Aug. 3, 2021 /PRNewswire/ — CartiHeal Ltd, developer of Agili-C™,…
Read More » -
Biologics
Bone Therapeutics provides update on the progress of clinical studies
REGULATED INFORMATION JTA-004 Phase III top-line results planned first half September ALLOB Phase IIb currently on track but recruitment slow…
Read More »